VRDN

VIRIDIAN THERAPEUTICS INC

Healthcare | Mid Cap

-$1.03

EPS Forecast

$5.58

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Proximilar's AI forecasts

EPS Forecast:

-$1.03

Revenue Forecast:

$5.58

EPS Surprise Forecast:

$0.008

Revenue Surprise Forecast:

-$0

Post-release price volatility - High

Post-release Overnight Move:

±8.7%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

54%

Probability of beating revenue consensus:

51%

Probability of beating both EPS & revs consensus:

34%

Probability of missing both EPS & revs consensus:

29%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-3

Beta (β)

Forward Looking Beta (β):

0.08

Earnings volatility

EPS standard deviation:

$0.37

Revenue standard deviation:

$14

As % of share price:

2.02% EXTREME UNCERTAINTY

As % of market cap:

0.66% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

-$0.56

Revenue 95th %ile:

$23

EPS 75th %ile:

-$0.91

Revenue 75th %ile:

$10

EPS 25th %ile:

-$1.14

Revenue 25th %ile:

$2

EPS 5th %ile:

-$1.45

Revenue 5th %ile:

-$9

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

39% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

100% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$17

Bid-ask per Share:

$0.03